Independent side-by-side comparison with pricing, specs, and clinical evidence.
Last updated: 2026-04-09
Why This Comparison Matters
Halo and Fraxel Dual sit in the same skin resurfacing category but take different approaches. Halo (Sciton) uses Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass) while Fraxel Dual (Solta Medical) uses Dual-Wavelength Non-Ablative Fractional Laser (1550nm + 1927nm). Both received FDA clearance (2015 and 2008 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $145,000-$210,000 (as Joule module) to $95,000-$145,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
Side-by-Side Specifications
Halo
Fraxel Dual
Manufacturer
Sciton
Solta Medical
Technology
Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass)
Technology: Hybrid Fractional Laser (1470nm non-ablative + 2940nm ablative in a single pass). First and only hybrid fractional laser that delivers ablative and non-ablative wavelengths in a single pass. Dynamic Thermal Optimization adjusts energy in real-time to maintain target temperature.
Fraxel Dual
Technology: Dual-Wavelength Non-Ablative Fractional Laser (1550nm + 1927nm). First fractional laser approved for melasma. Dual wavelengths target both deeper texture issues (1550nm) and superficial tone and pigment (1927nm).
Strong peer-reviewed base. Multiple blinded-evaluator studies showing significant improvement in photodamage, fine lines, and skin tone.
Fraxel Dual
100+ published studies. The most-studied fractional laser platform in the aesthetic market.
Treatment Experience
Halo
30-45 minutes per session. Recommended protocol: 1-3 sessions spaced 4-6 weeks apart. Treatment areas: Face, Neck, Decolletage, Hands, Arms. Patients typically tolerate this platform well when operated by trained clinicians.
Fraxel Dual
20-45 minutes per session. Recommended protocol: 3-5 sessions spaced 2-4 weeks apart. Treatment areas: Face, Neck, Decolletage, Hands. Patient experience varies by operator training and settings.
Practice Fit
Halo
High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Joule ecosystem.
Fraxel Dual
Dermatology practices that treat melasma and photodamaged skin on mixed patient populations. Practices that value brand recognition and a deep evidence base.
Pros and Cons
Halo Pros
Hybrid ablative plus non-ablative design in one pass
Dynamic Thermal Optimization keeps results consistent across passes
Built on the Sciton Joule platform alongside BBL and MOXI modules
Strong premium positioning supports high per-session pricing
Halo Cons
Joule platform pricing runs well above category competitors
Requires 3-5 days of social downtime (sandpaper texture)
Operator training is involved and takes weeks to master
Fraxel Dual Pros
Longest-running brand recognition in fractional skin resurfacing
FDA-cleared for melasma, an indication few competitors hold
Dual wavelengths address texture and tone in one device
Established safety profile across skin types
Fraxel Dual Cons
Solta parent Bausch Health carries heavy debt load
Older platform loses ground to newer hybrid lasers like Halo
Consumable tip costs add up at higher treatment volumes
The Verdict
Choose Halo if your practice prioritizes Sciton's ecosystem, brand recognition, or specific clinical advantages. High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Joule ecosystem. The pros that matter most: Hybrid ablative plus non-ablative design in one pass; Dynamic Thermal Optimization keeps results consistent across passes. The biggest tradeoff to accept: Joule platform pricing runs well above category competitors.
Choose Fraxel Dual if Solta Medical's positioning fits better. Dermatology practices that treat melasma and photodamaged skin on mixed patient populations. Practices that value brand recognition and a deep evidence base. The pros that matter most: Longest-running brand recognition in fractional skin resurfacing; FDA-cleared for melasma, an indication few competitors hold. The biggest tradeoff to accept: Solta parent Bausch Health carries heavy debt load.
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Halo used units run $80,000-$140,000; Fraxel Dual used units run $35,000-$70,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
Frequently Asked Questions
Which is more expensive, Halo or Fraxel Dual?
Halo runs $145,000-$210,000 (as Joule module) new and $80,000-$140,000 used. Fraxel Dual runs $95,000-$145,000 new and $35,000-$70,000 used. Per-session pricing is $1,200-$2,500 for Halo and $900-$1,800 for Fraxel Dual. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Halo or Fraxel Dual?
Halo clinical evidence: Strong peer-reviewed base. Multiple blinded-evaluator studies showing significant improvement in photodamage, fine lines, and skin tone. Fraxel Dual clinical evidence: 100+ published studies. The most-studied fractional laser platform in the aesthetic market. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Halo or Fraxel Dual more popular in dermatology practices?
Both Halo and Fraxel Dual are commonly used in dermatology, plastic surgery practices. Market share in any given category shifts year to year. Sciton and Solta Medical both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Halo or Fraxel Dual?
Both devices are FDA cleared and have established safety profiles. Halo has these documented concerns: Joule platform pricing runs well above category competitors. Fraxel Dual has: Solta parent Bausch Health carries heavy debt load. Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Halo and Fraxel Dual in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Halo and Fraxel Dual?
Used Halo sells for $80,000-$140,000 on the secondary market. Used Fraxel Dual sells for $35,000-$70,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.
Get Device Pulse every Tuesday
Weekly price tracker, FDA clearances, safety signals, and clinical evidence summaries. The only newsletter built for physicians who buy equipment.